(PharmaNewsWire.Com, May 17, 2017 ) Asia-Pacific Nuclear Imaging Market research report published by Market Data Forecast estimates that the market is growing with a CAGR of 9.64% to reach USD 4.96 billion by 2021, from USD 3.13 billion in 2016, which amounts to a cumulative growth of USD 1.51 billion.
Medical imaging is the method of making a visual image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.
The capability to generate pictures of a patients internal anatomy and alter them to film through diagnostic imaging has transformed the way many diseases and injuries are spotted, diagnosed, and treated. This market has applications in several medical arenas like cardiology, neurology, and orthopaedics. Internationally, most of the industrialized nations are spending a huge part of their GDP on healthcare necessities. The US is set to devote almost 20% of its GDP on healthcare by 2017, a higher proportion than any other developed country.
The report also presents detailed analysis of multitude of factors affecting Asia-Pacific Nuclear Imaging Market bearing either positive or negative outcomes. Some of those factors are Increase in the number of cancer and cardiovascular disease cases Predilection towards minimally invasive procedures Ready availability of radiopharmaceuticals Improving healthcare infrastructure in developing markets Costly procedures & equipment Inadequate number of trained medical staff Shortage of supplies
For granular level understanding, the Asia-Pacific Nuclear Imaging Market is segmented based on Diagnostic Technologies and Application each being provided with Market Size Estimations and Y-o-Y Forecasts. The market for Nuclear Imaging, on the basis of Diagnostic Technologies is segmented into PET Radioisotopes and SPECT Radioisotopes. PET Radioisotopes are further segmented into Rubidium-82, Fluorine-18, whereas SPECT Radioisotopes are, further segmented into Thallium-201, Technetium-99m, Xenon-133, and Iodine-123. On the basis of Application, the Nuclear Imaging market is segmented into PET and SPECT. PET is further segmented into Cardiology, Oncology, and Neurology, whereas SPECT is segmented into Lymphoma, Neurology, Cardiology, and Thyroid.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Among Asia-Pacific countries, India, Japan, and Australia will be the substantial markets due to growing healthcare budgets and rising popularity of several radiopharmaceuticals in numerous clinical indications.
Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution. The major companies dominating the Nuclear Imaging market in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.
The Asia-Pacific Nuclear Imaging Market report offers wide-range of scope:
Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
Know more about key areas of industry growth via detailed Segment-level analysis on basis of product, Lead type and End User with market size forecasts and y-o-y estimations
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Asia-Pacific Nuclear Imaging Market:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
